描述

Migration assay data for prostate cancer cells following melatonin treatment, indicating reduced migratory capacity in CRPC cell lines exposed to MLT.

Figure 6

Chart

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 6: Migration assay data for prostate cancer cells following melatonin treatment, indicating reduced migratory capacity in CRPC cell lines exposed to MLT.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Migration assay data for prostate cancer cells following melatonin treatment, indicating reduced migratory capacity in CRPC cell lines exposed to MLT." />
  <figcaption>Figure 6. Migration assay data for prostate cancer cells following melatonin treatment, indicating reduced migratory capacity in CRPC cell lines exposed to MLT.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

描述

Figure 6

Source Paper

Cite This Figure

相关证据